Table 3.
Characteristics of Patients Who Developed Lung Cancer
| Histology | Days Before Onset | Stage | Therapy | Outcome | Supplement | |
|---|---|---|---|---|---|---|
| 1. 61-yr M | Ad | 41 | pT1aN0M0 IA1 | Ope | Survival | |
| 2. 66-yr M | Ad | 1042 | pT1bN0M0 IA2 | Ope | Survival | |
| 3. 78-yr M | Ad | 931 | cT1aN0M0 IA1 | RT | Survival | |
| 4. 65-yr M | Ad | 247 | cT3N2M0 IIIB | Chemo | Survival | |
| 5. 66-yr M | Ad | 1133 | cT1bN0M0 IA2 | RT | Survival | |
| 6. 74-yr M | Ad | 1918 | cT1bN0M0 IA2 | Ope | Survival | Complication of interstitial pneumonia |
| 7. 76-yr M | Sq | 181 | pT1aN0M0 IA1 | Ope | Survival | |
| 8. 67-yr M | Sq | 392 | pT1bN0M0 IA2 | Ope | Survival | Complication of interstitial pneumonia |
| 9. 67-yr M | Sq | 929 | pT1bN0M0 IA2 | Ope | Survival | |
| 10. 78-yr M | Non-small | 95 | pT1bN0M0 IA2 | Ope | Survival | |
| 11. 70-yr M | Small | 317 | cT3N2M0 IIIB | Chemo | Death (Lung cancer) | |
| 12. 68-yr M | Small | 1019 | cT3N2M0 шB | BSC | Death (Interstitial pneumonia) | Complication of interstitial pneumonia |
| 13. 80-yr M | Clinical | 941 | cT1aN0M0 IA1 | RT | Death (Unknown) | |
| 14. 77-yr M | Clinical | 968 | cT1aN0M0 IA1 | RT | Death (Unknown) | |
| 15. 78-yr M | Clinical | 217 | cT2aN0M1a IVA | BSC | Death (Senility) | Due to poor pulmonary function, treatment could not be performed |
| 16. 79-yr M | Clinical | 643 | cT2aN0M0 IB | BSC | Death (Lung cancer) | The patient did not want to be examined and treated |
| 17. 86-yr M | Clinical | 817 | cT1aN0M0 IA1 | BSC | Survival | The patient did not want to be examined and treated |
| 18. 61-yr M | Clinical | 1444 | cT3N0M0 IIIB | BSC | Survival | Due to poor pulmonary function, treatment could not be administered |
| 19. 77-yr M | Clinical | 1500 | cT1aN0M0 IA1 | BSC | Death (Pancreatic cancer) | The patient did not want to be examined and treated |
Abbreviations: Ad, adenocarcinoma; Sq, squamous cell carcinoma; Small, small cell carcinoma; Ope, operation; RT, radiation therapy; Chemo, chemotherapy; BSC, best supportive care.